Home/Filings/4/0001247319-05-000070
4//SEC Filing

CYTYC CORP 4

Accession 0001247319-05-000070

CIK 0000849778operating

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 2:52 PM ET

Size

8.6 KB

Accession

0001247319-05-000070

Insider Transaction Report

Form 4
Period: 2005-10-03
LINDER JAMES
Sr. VP, Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2005-10-03$27.59/sh5,000$137,9472,663 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2005-10-035,00055,000 total
    Exercise: $3.25From: 2001-04-28Exp: 2008-04-28Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2005-10-03$3.25/sh+5,000$16,2507,663 total
Footnotes (3)
  • [F1]The stock options were acquired pursuant to Issuer's 1995 Stock Plan in transactions exempt from Section 16 under Rule 16b-3.
  • [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted in accordance with SEC Rule 10b5-1 on February 11, 2005.
  • [F3]Price not applicable to this transaction.

Issuer

CYTYC CORP

CIK 0000849778

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000849778

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 2:52 PM ET
Size
8.6 KB